Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy

Echocardiographic study of paediatric patients with mucopolysaccharidosis

(2010) Gabriela N. Leal et al.   CARDIOLOGY IN THE YOUNG

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

(2010) Paul Harmatz et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council

(2010) Leo Lopez et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses

(2009) Vlasta Fesslová et al.   CARDIOLOGY IN THE YOUNG

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study

(2009) JJ McGill et al.   CLINICAL GENETICS

Mucopolysaccharidosis VI: the Italian experience

(2009) Maurizio Scarpa et al.   EUROPEAN JOURNAL OF PEDIATRICS

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

(2009) Helmut Baumgartner et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Regression Equations for Calculation of Z Scores of Cardiac Structures in a Large Cohort of Healthy Infants, Children, and Adolescents: An Echocardiographic Study

(2008) Michael D. Pettersen et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

(2008) Paul Harmatz et al.   MOLECULAR GENETICS AND METABOLISM